About Us

Israeli Innovation

Headquartered in Tel Aviv, Israel, Taffix was developed and manufactured by Nasus Pharma, an innovative company in the development of intranasal powder-based products for a wide range of acute, life-threatening indications, where prompt treatment and speedy delivery is of the essence.

Prior to the current pandemic, we had already spent 3 years of R&D on different intranasal indications. In early 2020, when the magnitude of Covid-19 was becoming apparent, we immediately redirected all of our efforts to bring Taffix to market as soon as possible. We wouldn’t have done it without the sleepless nights of all our team, and for that we will always be grateful.

Board of directors